171 related articles for article (PubMed ID: 17890854)
21. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.
Boor P; Celec P; Behuliak M; Grancic P; Kebis A; Kukan M; Pronayová N; Liptaj T; Ostendorf T; Sebeková K
Metabolism; 2009 Nov; 58(11):1669-77. PubMed ID: 19608208
[TBL] [Abstract][Full Text] [Related]
22. Role of megalin, a proximal tubular endocytic receptor, in the pathogenesis of diabetic and metabolic syndrome-related nephropathies: protein metabolic overload hypothesis.
Saito A; Takeda T; Hama H; Oyama Y; Hosaka K; Tanuma A; Kaseda R; Ueno M; Nishi S; Ogasawara S; Gondaira F; Suzuki Y; Gejyo F
Nephrology (Carlton); 2005 Oct; 10 Suppl():S26-31. PubMed ID: 16174284
[TBL] [Abstract][Full Text] [Related]
23. Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE proteins.
Deuther-Conrad W; Franke S; Sommer M; Henle T; Stein G
Kidney Int Suppl; 2001 Feb; 78():S63-6. PubMed ID: 11168985
[TBL] [Abstract][Full Text] [Related]
24. Advanced glycation end-products induce calpain-mediated degradation of ezrin.
McRobert EA; Young AN; Bach LA
FEBS J; 2012 Sep; 279(17):3240-50. PubMed ID: 22805611
[TBL] [Abstract][Full Text] [Related]
25. Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells.
Lee YJ; Lee YJ; Han HJ
Kidney Int Suppl; 2007 Aug; (106):S27-35. PubMed ID: 17653207
[TBL] [Abstract][Full Text] [Related]
26. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
Kanková K
Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
[TBL] [Abstract][Full Text] [Related]
27. Reabsorption of native and glycated albumin by renal proximal tubular epithelial cells.
Bendayan M; Londoño I
Am J Physiol; 1996 Aug; 271(2 Pt 2):F261-8. PubMed ID: 8770156
[TBL] [Abstract][Full Text] [Related]
28. Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-beta1 enhanced IL-18 expression in human renal proximal tubular epithelial cells.
Miyauchi K; Takiyama Y; Honjyo J; Tateno M; Haneda M
Diabetes Res Clin Pract; 2009 Feb; 83(2):190-9. PubMed ID: 19110334
[TBL] [Abstract][Full Text] [Related]
29. Megalin-dependent internalization of cadmium-metallothionein and cytotoxicity in cultured renal proximal tubule cells.
Wolff NA; Abouhamed M; Verroust PJ; Thévenod F
J Pharmacol Exp Ther; 2006 Aug; 318(2):782-91. PubMed ID: 16690719
[TBL] [Abstract][Full Text] [Related]
30. Human recombinant lysozyme downregulates advanced glycation endproduct-induced interleukin-6 production and release in an in-vitro model of human proximal tubular epithelial cells.
Gallo D; Cocchietto M; Masat E; Agostinis C; Harei E; Veronesi P; Sava G
Exp Biol Med (Maywood); 2014 Mar; 239(3):337-46. PubMed ID: 24495950
[TBL] [Abstract][Full Text] [Related]
31. The involvement of advanced glycation endproducts (AGEs) in renal injury of diabetic glomerulosclerosis: association with phenotypic change in renal cells and infiltration of immune cells.
Mao Y; Ootaka T; Saito T; Sato H; Sato T; Ito S
Clin Exp Nephrol; 2003 Sep; 7(3):201-9. PubMed ID: 14586716
[TBL] [Abstract][Full Text] [Related]
32. Endocannabinoids and the renal proximal tubule: an emerging role in diabetic nephropathy.
Jenkin KA; Verty AN; McAinch AJ; Hryciw DH
Int J Biochem Cell Biol; 2012 Nov; 44(11):2028-31. PubMed ID: 22842535
[TBL] [Abstract][Full Text] [Related]
33. Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding.
Youssef S; Nguyen DT; Soulis T; Panagiotopoulos S; Jerums G; Cooper ME
Kidney Int; 1999 Mar; 55(3):907-16. PubMed ID: 10027927
[TBL] [Abstract][Full Text] [Related]
34. Glycation in diabetic nephropathy.
Forbes JM; Cooper ME
Amino Acids; 2012 Apr; 42(4):1185-92. PubMed ID: 20963456
[TBL] [Abstract][Full Text] [Related]
35. Advanced glycation end products impair protein turnover in LLC-PK1: amelioration by trypsin.
Xiang G; Schinzel R; Simm A; Sebekova K; Heidland A
Kidney Int Suppl; 2001 Feb; 78():S53-7. PubMed ID: 11168983
[TBL] [Abstract][Full Text] [Related]
36. Two analytical methods to study the interaction of AGEs with cell surface proteins.
Schmitt A; Meiners I; Schmitt J; Nöller J; Ihling C; Münch G; Sinz A; Nieber K
J Biochem Biophys Methods; 2005 Dec; 65(2-3):121-36. PubMed ID: 16364447
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
38. Pathological roles of advanced glycation end product receptors SR-A and CD36.
Horiuchi S; Unno Y; Usui H; Shikata K; Takaki K; Koito W; Sakamoto Y; Nagai R; Makino K; Sasao A; Wada J; Makino H
Ann N Y Acad Sci; 2005 Jun; 1043():671-5. PubMed ID: 16037291
[TBL] [Abstract][Full Text] [Related]
39. High glucose reduces albumin uptake in cultured proximal tubular cells (LLC-PK1).
Ishibashi F
Diabetes Res Clin Pract; 2004 Sep; 65(3):217-25. PubMed ID: 15331201
[TBL] [Abstract][Full Text] [Related]
40. Investigation of pathways of advanced glycation end-products accumulation in macrophages.
Nagai R; Fujiwara Y; Mera K; Otagiri M
Mol Nutr Food Res; 2007 Apr; 51(4):462-7. PubMed ID: 17390398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
